These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7496198)

  • 21. An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
    Foulkes JR
    J Trop Med Hyg; 1975 Apr; 78(4):72-4. PubMed ID: 1152100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.
    Blum J; Nkunku S; Burri C
    Trop Med Int Health; 2001 May; 6(5):390-400. PubMed ID: 11348533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
    Rodgers J; Bradley B; Kennedy PG
    Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):96-100. PubMed ID: 13638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
    Scena MR
    Cent Afr J Med; 1988 Nov; 34(11):264-8. PubMed ID: 3252975
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.
    Legros D; Evans S; Maiso F; Enyaru JC; Mbulamberi D
    Trans R Soc Trop Med Hyg; 1999; 93(4):439-42. PubMed ID: 10674099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective long-term study of effects of berenil by follow-up of patients treated since 1965.
    Abaru DE; Liwo DA; Isakina D; Okori EE
    Tropenmed Parasitol; 1984 Sep; 35(3):148-50. PubMed ID: 6495383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.
    Adams JH; Haller L; Boa FY; Doua F; Dago A; Konian K
    Neuropathol Appl Neurobiol; 1986; 12(1):81-94. PubMed ID: 3703156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current status of trypanosomiasis].
    Dumas M; Bouteille B
    Med Trop (Mars); 1997; 57(3 Suppl):65-9. PubMed ID: 9513181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.
    Pepin J; Milord F
    Trans R Soc Trop Med Hyg; 1991; 85(2):222-4. PubMed ID: 1887477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Three patients with African sleeping sickness following a visit to Tanzania].
    Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sleeping sickness in children at Bobo-Dioulasso Hospital Center: apropos of 3 cases].
    Millogo A; Nacro B; Bonkoungou P; Sanou M; Traoré S; Traoré H; Tall F
    Bull Soc Pathol Exot; 1999 Dec; 92(5):320-2. PubMed ID: 10690468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
    Arroz JO
    Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.